Eli Lilly has officially crossed the $1 trillion valuation mark, becoming the first pharmaceutical company in history to join a market-cap club previously dominated almost entirely by technology giants. The milestone reflects a dramatic reshaping of the healthcare landscape, driven by surging global demand for next-generation weight-loss and metabolic health treatments.
Lilly’s rise has been nothing short of extraordinary. The company’s stock has rallied more than 35% this year alone, fueled largely by explosive growth in the obesity-drug category. Over the past two years, new and highly effective treatments have transformed weight-loss medicine into one of the most profitable segments in all of healthcare. What was once a niche market is now a multibillion-dollar engine attracting unprecedented consumer, medical, and investor interest.
At the center of Lilly’s success are two blockbuster drugs: tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for obesity. Together, they have rapidly climbed to the top of global pharmaceutical sales charts, surpassing even Merck’s cancer drug Keytruda — long considered untouchable as the world’s best-selling medication.
Although rival Novo Nordisk pioneered the modern obesity-drug movement with Wegovy, Lilly seized momentum after early supply shortages hampered Wegovy’s rollout. Stronger clinical results, faster manufacturing scale-up, and broader distribution helped Lilly pull ahead in prescriptions and capture the spotlight as the dominant player in the sector.
The company’s latest quarterly results underscore that shift. Lilly generated more than $10 billion in revenue from its obesity and diabetes medicines—over half of its total $17.6 billion in quarterly sales. Investors now value the company at nearly 50 times its expected earnings, signaling confidence that demand for metabolic-health treatments will remain powerful for years.
The broader market seems convinced as well. Since Zepbound’s launch in late 2023, Lilly shares have surged more than 75%, outpacing the S&P 500’s impressive run. Wall Street analysts estimate the global weight-loss drug market could reach $150 billion by 2030, with Lilly and Novo Nordisk expected to control the vast majority of those sales.
Looking ahead, investors are closely watching Lilly’s upcoming oral obesity drug, orforglipron, which could receive approval as early as next year. Analysts expect it to extend the company’s dominance by offering a pill-based alternative to injectable GLP-1 medications—an option that could unlock even wider adoption.
Beyond drug development, Lilly’s growth is poised to benefit from planned U.S. manufacturing expansions and a federal pricing agreement that is expected to increase patient access. Although the deal may reduce short-term revenue per dose, analysts believe the expanded eligibility—potentially adding tens of millions of U.S. patients—will dramatically enlarge the long-term market.
With its market cap now rivaling major tech players, Lilly is increasingly being viewed as a “Magnificent Seven-style” stock again—an alternative for investors seeking high-growth prospects outside AI and digital infrastructure. Still, challenges remain, including pricing pressure and the need to sustain manufacturing capacity at unprecedented scale.
For now, Lilly’s ascent to the $1 trillion tier signals a new era in which metabolic-health innovation, not just technology, can redefine global market leadership.
US consumer sentiment weakened again in November, underscoring the growing strain households feel from higher prices, softer income growth, and persistent anxiety about job security. Despite a modest improvement after the government shutdown ended, consumers remain broadly pessimistic and increasingly concerned about their financial future.
According to the University of Michigan’s final November reading, overall sentiment ticked up slightly to 51 after briefly plunging earlier in the month. But even with the rebound, confidence remains well below October’s level and sits nearly 30% lower than a year ago. For many Americans, the temporary resolution of the government funding crisis brought some short-term relief, but not enough to offset the everyday pressure of rising costs and weaker purchasing power.
One major factor weighing on households is continued inflation. While expectations for year-ahead inflation edged down to 4.5%, most consumers say they still feel the squeeze from higher prices for essentials like food, rent, utilities, and healthcare. The anticipated jump in health insurance premiums heading into 2026 has added another layer of financial worry, especially for families already stretched thin.
Incomes are another pain point. Many workers report that their earnings aren’t keeping up with rising costs, leading to a decline of about 15% in consumers’ assessments of their current financial situation. Even individuals who felt secure earlier in the fall have grown more cautious as the economic outlook becomes increasingly uncertain.
Labor-market concerns are also accelerating. The unemployment rate is higher than a year ago, and layoffs across several industries have heightened anxiety. Nearly seven out of ten consumers now expect unemployment to rise over the next year — more than double the share from this time in 2024. Many also feel more vulnerable personally, with the perceived likelihood of job loss rising to its highest point since 2020.
The mood among younger adults is even more troubling. For Americans aged 18 to 34, expectations around job loss over the next five years have climbed to their highest level in more than a decade. Younger workers, many of whom are early in their careers or managing student loan burdens, are increasingly uneasy about their career stability and long-term financial prospects.
Even wealthier households are not immune. Consumers with large stock holdings initially saw sentiment improve earlier in November, but market declines wiped out those gains. Volatile markets combined with the broader economic uncertainty have contributed to renewed caution among investors and higher-income earners.
Overall, the November data paints a picture of an economy where the shutdown may have ended, but its psychological impact lingers. With government funding only secured through January, uncertainty about future disruptions remains. Households are preparing for the possibility of more instability at a time when budgets are already strained.
The combination of stubborn inflation, weakening income growth, elevated recession fears, and unstable policy conditions continues to erode Americans’ confidence. While the economy has avoided a sharp downturn so far, consumers appear increasingly doubtful that the months ahead will bring meaningful improvement.
The Federal Reserve’s December policy decision has become significantly more complicated following the release of the long-delayed September jobs report. After weeks of uncertainty caused by the government shutdown, economists were hoping the data would offer at least some directional clarity. Instead, the report delivered a contradictory mix of signals that has left markets, analysts, and policymakers struggling to determine whether the Fed’s next move will be a rate cut — or simply holding steady.
On the surface, the headline numbers appeared encouraging. Employers added 119,000 jobs in September, more than double what forecasters had anticipated. In a typical environment, that level of job creation would be considered firm evidence that the labor market still retains momentum.
However, the rest of the report painted a more complicated — and in some ways troubling — picture. The unemployment rate nudged higher to 4.4%, and on an unrounded basis reached 4.44%, inching close to the 4.5% threshold that some Fed officials view as a sign that labor conditions may be softening. Layered on top of that is the fact that this data is nearly two months old. Because of the shutdown, the Labor Department will not release an October report at all, and the November report will not be available until after the Fed meets in mid-December. As a result, policymakers are attempting to make a major policy decision with limited, stale visibility.
Another challenge is the unusually choppy pattern of job creation over the last several months. Hiring dipped into negative territory in June, rebounded in July, contracted again in August after revisions, and then jumped higher in September. This volatility makes it difficult to determine whether the labor market is gradually slowing or simply experiencing temporary fluctuations after several years of rapid post-pandemic recovery.
A significant structural factor shaping recent trends is the slowdown in immigration. With fewer new workers entering the labor force, the “break-even” number of jobs needed to maintain a stable unemployment rate has decreased to an estimated 30,000 to 50,000 per month. Since September’s job gains far exceeded that range, it indicates that demand for labor remains healthier than the rising unemployment rate alone suggests.
Sector-level data also highlights a mixed landscape. Industries such as healthcare and hospitality continue to show notable strength, reflecting persistent consumer demand and structural labor shortages. Meanwhile, other sectors have begun to lose momentum, reinforcing the idea that the labor market is no longer uniformly strong but instead is becoming more uneven.
Overall, the economy has added an average of 76,000 jobs per month so far in 2025 — a pace that aligns with the lower growth environment of a cooling, but still functioning, labor market.
Inside the Fed, opinions remain divided. Some policymakers believe easing rates further is consistent with guiding monetary policy back toward a neutral setting. Others see the recent uptick in unemployment, combined with limited fresh data, as reasons to pause. Financial markets reflect this uncertainty as well, with traders now assigning roughly even odds to a December rate cut.
For now, the September report provides more ambiguity than clarity. Without current data and with mixed signals across key indicators, the Fed enters its next policy meeting navigating perhaps its murkiest environment of the year.
MALVERN, Pa., Nov. 20, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-founder of Ocugen will present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex in Boca Raton, FL.
“I look forward to sharing the meaningful progress Ocugen has made toward our goal of three BLAs in three years, along with updates on exciting near-term catalysts in 2026, during this important conference,” said Dr. Musunuri. “NobleCon provides a forum to differentiate Ocugen’s scientific platform among our peers in ophthalmology and share how we are addressing major blindness diseases with a single, one-time gene therapy for life.”
Details regarding the presentation and fireside chat are as follows: Date: Wednesday, December 3, 2025 Location: Presentation Room 2 Time: 1 p.m. ET
In addition to Dr. Musunuri’s session, members of Ocugen’s executive team will conduct one-on-one meetings with investors to highlight the Company’s business and clinical development strategy across its unique modifier gene therapy platform.
A high-definition video webcast of the presentation will be available the following day on the Company’s website, and as part of a complete catalog of presentations available at Noble Capital Markets’ Conference website and on Channelchek, the investor portal created by Noble. The webcast will be archived on the Company’s website, the NobleCon website, and Channelchek.com for 90 days following the event.
About Ocugen, Inc. Ocugen, Inc. is a pioneering biotechnology leader in gene therapies for blindness diseases. Our breakthrough modifier gene therapy platform has the potential to address significant unmet medical need for large patient populations through our gene-agnostic approach. Unlike traditional gene therapies and gene editing, Ocugen’s modifier gene therapies address the entire disease—complex diseases that are potentially caused by imbalances in multiple gene networks. Currently we have programs in development for inherited retinal diseases and blindness diseases affecting millions across the globe, including retinitis pigmentosa, Stargardt disease, and geographic atrophy—late stage dry age-related macular degeneration. Discover more at www.ocugen.com and follow us on X and LinkedIn.
About Noble Capital Markets, Inc. Established in 1984, Noble Capital Markets (Noble) is an SEC/FINRA registered full-service broker-dealer offering investment/merchant banking and advisory services, with an award-winning research team, and a proprietary research distribution platform (Channelchek). Noble provides middle-market expertise to entrepreneurs, corporations, financial sponsors, and investors. In addition to its large scale in-person conference, NobleCon, Noble hosts multi-sector virtual conferences throughout the year. Over the more than 40 years, Noble has raised billions of dollars for companies and published more than 45,000 equity research reports. www.noblecapitalmarkets.com | www.nobleconference.com.
Cautionary Note on Forward-Looking Statements This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. We may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks, and uncertainties that may cause actual events or results to differ materially from our current expectations. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (SEC), including the risk factors described in the section entitled “Risk Factors” in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events, or otherwise, after the date of this press release.
Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.
Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Q3 Results. The company reported Q3 revenue of $1.1 million and an adj. EBITDA loss of $0.7 million, both of which were modestly lower than our estimates of $1.6 million and a loss of $0.2 million, respectively, as illustrated in Figure #1 Q3 Results. Notably, sales for C. Wonder and Christie Brinkley’s TWRHLL were disrupted by tariff-related vendor issues and HSN’s studio transition during Q3, which have since been resolved.
Strategic partnerships. The company’s new influencer brands, with Jenny Martinez, Gemma Stafford, Cesar Millan, and Coco Rocha, are expected to launch in Q1 2026. Notably, these celebrity partnerships drove the increase in the company’s social media following from 5 million at the start of the year to its current following of 46 million. In our view, the company is well positioned to reach its goal of 100 million social media followers in 2026.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
Gold prices pulled back as financial markets reassessed the likelihood of another Federal Reserve rate cut in December, following a US jobs report that delivered a blend of strength and weakness. The data added another layer of uncertainty to an already murky policy outlook, prompting traders to dial back expectations for imminent easing and pressuring precious metals in the process.
The September jobs report showed stronger-than-expected hiring, signaling that parts of the labor market still retain momentum. At the same time, the unemployment rate continued drifting upward, reinforcing concerns that underlying conditions may be gradually softening. The combination of firm job creation and rising unemployment has made it harder for investors to predict how the Fed will interpret the data heading into its December 9–10 meeting.
This jobs report will be the last major labor market reading the central bank receives before making its next policy decision. With no October report released due to government delays, policymakers are entering December with limited visibility, relying heavily on data that may not fully reflect current conditions. That uncertainty has fed directly into market expectations for precious metals.
Traders had already stepped back from the idea of a December rate cut even before the employment data was released. The cancellation of the October jobs report raised doubts about whether the Fed would feel confident enough to ease further without fresh, reliable readings. After the September data, market activity briefly nudged probability forecasts slightly higher, but not enough to shift the broader view: investors still see less than a 50% chance of a cut next month.
Gold typically struggles in environments where rate cuts are uncertain. Higher interest rates lift Treasury yields and strengthen the US dollar — both of which reduce the appeal of non-yielding assets like bullion. That dynamic weighed on the metal after the jobs report, contributing to the latest pullback.
Fed officials also remain divided in their public remarks. Some members have expressed caution about further easing, citing concerns that recent inflation progress may have stalled. That has fueled additional skepticism among traders and added pressure across the precious metals complex. Broad-based losses in silver, platinum, and palladium further reflected the market’s defensive posture.
Despite the recent dip, gold remains one of the year’s strongest-performing major assets. The metal has surged more than 50% year-to-date, boosted by the Fed’s earlier rate cuts, persistent central bank demand, and strong inflows into bullion-backed ETFs. Prices hit a record high in October before moderating as policy uncertainty grew. Even with the latest volatility, gold remains firmly supported by longer-term structural drivers, including geopolitical tensions and ongoing diversification efforts among global reserve managers.
As of early afternoon in New York, gold was trading around $4,059 an ounce, while the US dollar saw modest gains. With inflation concerns stirring again and the labor market sending mixed signals, traders are preparing for a December decision that could go either way — and gold is likely to remain sensitive to every shift in the outlook.
In a landmark week for U.S.–Saudi relations, Washington has secured $1 trillion in Saudi spending commitments, dramatically expanding the scope of agreements announced just six months ago. The visit of Crown Prince Mohammed bin Salman—paired with President Donald Trump’s high-profile welcome—signaled a strategic deepening of political, economic, and defense ties between the two countries.
The new commitment, up from the previously announced $600 billion, underscores Saudi Arabia’s broad push to accelerate technological modernization, diversify its economy, and cement key alliances as global power centers shift. The Crown Prince is expected to meet with top U.S. corporate leaders, further strengthening private-sector alignment across both nations.
Nuclear Energy Becomes a Central Pillar
One of the most consequential announcements is the signing of a bilateral nuclear cooperation pact, laying the foundation for decades of collaboration in civilian nuclear infrastructure. Although progress had long stalled due to U.S. restrictions on uranium enrichment, the deal approved this week does not allow enrichment, sticking to strict nonproliferation requirements.
For Saudi Arabia, nuclear power is a cornerstone of its long-term energy transition strategy. For the U.S., the agreement secures American firms as preferred partners—locking out geopolitical competitors seeking influence in the region.
In parallel, Saudi Aramco revealed 17 new agreements with major U.S. companies, worth more than $30 billion, expanding joint ventures across refining, chemicals, and cutting-edge energy technologies.
Critical Minerals: A Geopolitical Priority
A new U.S.–Saudi critical minerals framework marks another major strategic milestone. As the U.S. works to reduce dependency on China for rare earth elements, the Saudis are emerging as a key partner in building diversified, secure supply chains.
Complementing the pact, MP Materials announced plans—backed by the U.S. Department of Defense and Saudi mining giant Maaden—to construct a rare earths refinery in the kingdom. This positions Saudi Arabia as a future hub for minerals essential to EVs, clean energy, and advanced defense technologies.
AI and Supercomputing Collaboration Expands
Artificial intelligence took center stage as the two nations signed a broad AI memorandum of understanding. The agreement grants Saudi Arabia access to U.S. AI capabilities at a scale previously unmatched.
Technology leader Nvidia confirmed that it will collaborate with Saudi Arabia to develop new supercomputing infrastructure—a critical building block for advanced AI research, autonomous systems, and next-generation digital industries.
Defense: A Major Realignment
A new strategic defense agreement reaffirms the 80-year U.S.–Saudi alliance while easing operational barriers for American defense firms. Although it falls short of a NATO-style treaty, the pact introduces new burden-sharing commitments and modernizes joint security frameworks.
Perhaps most notably, the U.S. approved future deliveries of F-35 fighter jets to Saudi Arabia—marking the first time the aircraft will be sold to a Middle Eastern nation other than Israel. Riyadh will also purchase 300 American tanks as part of a broader defense modernization push.
Trade, Finance, and Capital Markets
Additional accords strengthen cooperation on trade, capital markets technology, financial regulations, and cross-border investment standards. These agreements aim to expand U.S. exports while opening new pathways for American companies operating in global markets.
Collectively, the $1 trillion package represents one of the most sweeping and strategically significant investment commitments ever exchanged between the two countries—reshaping global alliances in energy, technology, defense, and economic policy for years to come.
SKYX is Expected to Supply 15,000 Units Including its Advanced Smart Plug & Play Technologies comprising Ceiling Lighting, Ceiling Fans, Recessed Lights, Down Lights, EXIT Signs, Emergency Lights, Indoor and Outdoor Wall Lights Among Other Advanced Smart Products
Landmark Companies are Prominent Developers with 27 Years of Experience Building Tens of Thousands of Units, Specializing in Modern Homes and Buildings with Over 3,000 Units in Development in Texas, Florida, and Colorado, Among Other Locations
SKYX and Landmark are Expected to Collaborate on Additional Upcoming Landmark Projects
SKYX’s Technologies Expansion Provides Additional Opportunities for Future Recurring Revenues Through Interchangeability, Upgrades, AI Services, Monitoring and Subscriptions, Among Others
MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with over 100 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes and buildings become safe and smart as the new standard, today announced that it will supply its advanced smart plug and play technologies to a 340 unit residential development project in San Antonio, Texas. The project will include 88 townhomes and 252 apartments. The development is led by prominent developers Landmark Companies. Amenities will include swimming pools, a state-of-the-art gym, modern meeting and conference facilities, landscaped green spaces, and more.
SKYX is expected to provide over 15,000 units of its advanced and smart plug & play technologies, including ceiling lighting, recessed lights, downlights, wall lights, EXIT, and EMERGENCY lights, plug-in LED backlight mirrors among other SKYX products.
Landmark Companies are prominent developers with 27 years of experience building tens of thousands of units specializing in modern homes and buildings in Texas, Florida and Colorado, among other locations.
Julia Baytler, CEO of Landmark Companies, said; “We are excited to continue collaborating with SKYX and bring their innovative technologies into our Austin Manor project. At Landmark, our focus has always been on creating modern, high-quality living spaces that enhance the daily lives of our residents. By integrating SKYX’s advanced plug-and-play solutions, we are raising the standard of safety, convenience, and design for our communities, and we look forward to expanding this collaboration across future developments.”
Rani Kohen, Founder and Executive Chairman, of SKYX Platforms, said; “We are very happy to be working with prominent developers like Landmark Companies. We look forward to collaborating with them to enhance home values while creating safer, more advanced, and smarter buildings for the future.”
As electricity is a standard in every home and building, our mission is to make homes and buildings become safe-advanced and smart as the new standard. SKYX has a series of highly disruptive advanced-safe-smart platform technologies, with over 100 U.S. and global patents and patent pending applications. Additionally, the Company owns over 60 lighting and home decor websites for both retail and commercial segments. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. We believe that our products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, please visit our website at https://skyplug.com/ or follow us on LinkedIn.
Forward-Looking Statements Certain statements made in this press release are not based on historical facts but are forward-looking statements. These statements can be identified by the use of forward-looking terminology such as “aim,” “anticipate,” “believe,” “can,” “could,” “continue,” “estimate,” “expect,” “evaluate,” “forecast,” “guidance,” “intend,” “likely,” “may,” “might,” “objective,” “ongoing,” “outlook,” “plan,” “potential,” “predict,” “probable,” “project,” “seek,” “should,” “target” “view,” “will,” or “would,” or the negative thereof or other variations thereon or comparable terminology, although not all forward-looking statements contain these words. These statements reflect the Company’s reasonable judgment with respect to future events and are subject to risks, uncertainties and other factors, many of which have outcomes difficult to predict and may be outside our control, that could cause actual results or outcomes to differ materially from those in the forward-looking statements. Such risks and uncertainties include statements relating to the Company’s ability to successfully launch, commercialize, develop additional features and achieve market acceptance of its products and technologies and integrate its products and technologies with third-party platforms or technologies; the Company’s efforts and ability to drive the adoption of its products and technologies as a standard feature, including their use in homes, hotels, offices and cruise ships; the Company’s ability to capture market share; the Company’s estimates of its potential addressable market and demand for its products and technologies; the Company’s ability to raise additional capital to support its operations as needed, which may not be available on acceptable terms or at all; the Company’s ability to continue as a going concern; the Company’s ability to execute on any sales and licensing or other strategic opportunities; the possibility that any of the Company’s products will become National Electrical Code (NEC)-code or otherwise code mandatory in any jurisdiction, or that any of the Company’s current or future products or technologies will be adopted by any state, country, or municipality, within any specific timeframe or at all; risks arising from mergers, acquisitions, joint ventures and other collaborations; the Company’s ability to attract and retain key executives and qualified personnel; guidance provided by management, which may differ from the Company’s actual operating results; the potential impact of unstable market and economic conditions on the Company’s business, financial condition, and stock price; and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including its periodic reports on Form 10-K and Form 10-Q. There can be no assurance as to any of the foregoing matters. Any forward-looking statement speaks only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by U.S. federal securities laws.
PONTE VEDRA, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) — Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoagulation therapy, today announced its Chairman and Chief Executive Officer, Quang X. Pham, received the prestigious BioFlorida, Inc. “Executive of the Year Award,” at the recently held Florida Innovation Conference, powered by BioFlorida, in Orlando.
As the voice of Florida’s life-science ecosystem, BioFlorida represents biotechnology, medical-technology, digital health and health system organizations across the state and is committed to advancing innovation, economic growth and patient-impacting therapies.
“Our Executive of the Year Award underscores the remarkable leadership and vision that Quang has brought to Cadrenal and to Florida’s biotech sector,” said Mark A. Glickman, CEO of BioFlorida. “He exemplifies the entrepreneurial spirit and patient-centric innovation that our state’s life sciences community stands for.”
Under Pham’s leadership, Cadrenal has uniquely positioned itself to address gaps in anticoagulation treatment of multiple indications through the development of two differentiated anticoagulants (tecarfarin and frunexian). He founded Cadrenal after a distinguished career that includes founding other life-science and digital-health firms, as well as service as a U.S. Marine Corps officer.
“I am deeply honored to receive this recognition from BioFlorida,” said Pham. “BioFlorida has been by our side from day one. Our team is motivated every day by the patients who have few options for safe and effective anticoagulation. This award is a tribute to all of them.”
About Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. is a biopharmaceutical company with a mission to develop novel and differentiated biopharmaceutical products that bridge critical gaps in current acute and chronic anticoagulant therapy. We bridge these gaps by developing novel and differentiated anticoagulants, or blood thinners, designed to provide greater predictability, increased stability, more precise control, and fewer bleeding complications. We currently have two clinical-stage assets: tecarfarin, an oral vitamin K antagonist (VKA) for chronic use, and frunexian, a parenteral small-molecule Factor XIa antagonist for use in acute hospital settings. By targeting underserved patient populations and advancing therapies designed for both chronic and acute use, we aim to reshape standards of care in anticoagulation. For more information, visit https://www.cadrenal.com/ and connect with the Company on LinkedIn.
Safe Harbor
Any statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements.” The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potentially,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These statements include statements regarding developing transformative therapeutics to overcome current gaps in anticoagulation therapy and positioning the Company to address gaps in anticoagulation treatment of multiple indications through the development of two differentiated anticoagulants. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the ability to develop transformative therapeutics to overcome current gaps in anticoagulation therapy, the ability to successfully complete clinical trials on time and achieve desired results and benefits as expected and the other risk factors described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, and the Company’s subsequent filings with the Securities and Exchange Commission, including subsequent periodic reports on Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Any forward-looking statements contained in this press release speak only as of the date hereof and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise.
First 10 Kiosk Pilot Installed, with Additional Deployments Planned Across the Retailer’s 200+ Locations
ATLANTA, Nov. 19, 2025 (GLOBE NEWSWIRE) — Bitcoin Depot (“Bitcoin Depot” or the “Company”) (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced a new retail partnership with Wild Bill’s Tobacco, one of America’s leading specialty tobacco retailers, with locations across Michigan, Ohio, Indiana, West Virginia, and Missouri. The collaboration will commence with a pilot installation of Bitcoin Depot kiosks in 10 Wild Bill’s stores with the opportunity to expand across the company’s portfolio of more than 250 stores in the future.
“We’re excited to welcome Wild Bill’s customers to our network as we expand our footprint and further advance our mission to make Bitcoin access simple, secure, and convenient,” said Scott Buchanan, President & COO of Bitcoin Depot. “By partnering with trusted, high-traffic retailers like Wild Bill’s, we meet customers where they already shop and ensure they can buy Bitcoin safely and easily while running everyday errands.”
Founded in 1994, Wild Bill’s is a well-established Midwest retailer known for its broad product selection and steady customer traffic. Its convenient neighborhood presence provides an accessible and convenient environment for customers to access Bitcoin while making everyday purchases.
“Wild Bill’s has always focused on providing customers with new, value-added services,” said Justin Samona, VP of Business Development for Wild Bill’s. “Partnering with Bitcoin Depot now brings a trusted crypto solution into our stores, and this pilot will allow our teams to fine-tune an intentional rollout and deliver the best customer experience, setting the stage for a broader expansion in the months ahead.”
About Bitcoin Depot Bitcoin Depot Inc. (Nasdaq: BTM) was founded in 2016 with the mission to connect those who prefer to use cash to the broader, digital financial system. Bitcoin Depot provides its users with simple, efficient and intuitive means of converting cash into Bitcoin, which users can deploy in the payments, spending and investing space. Users can convert cash to bitcoin at Bitcoin Depot kiosks in 47 states and at thousands of name-brand retail locations in 31 states through its BDCheckout product. The Company has the largest market share in North America with over 9,000 kiosk locations as of August 2025. Learn more at www.bitcoindepot.com.
About Wild Bill’s Founded in 1994 and headquartered in Troy, Michigan, Wild Bill’s Tobacco has grown to become the second largest tobacco retailer in the United States and the #1 retailer in Michigan. With more than 240 locations across Michigan, Ohio, West Virginia, Missouri, and Indiana, Wild Bill’s is committed to delivering the best selection of products at competitive prices while providing exceptional customer service. Inside every Wild Bill’s store, customers will also find a walk-in humidor stocked with premium cigars from around the world.
Cautionary Note Regarding Forward-Looking Statements This press release and any oral statements made in connection herewith include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. Forward-looking statements are any statements other than statements of historical fact, and include, but are not limited to, statements regarding the expectations of plans, business strategies, objectives and growth and anticipated financial and operational performance, including our growth strategy and ability to increase deployment of our products and services, the anticipated effects of the Amendment, and the closing of the Preferred Sale. These forward-looking statements are based on management’s current beliefs, based on currently available information, as to the outcome and timing of future events. Forward-looking statements are often identified by words such as “anticipate,” “appears,” “approximately,” “believe,” “continue,” “could,” “designed,” “effect,” “estimate,” “evaluate,” “expect,” “forecast,” “goal,” “initiative,” “intend,” “may,” “objective,” “outlook,” “plan,” “potential,” “priorities,” “project,” “pursue,” “seek,” “should,” “target,” “when,” “will,” “would,” or the negative of any of those words or similar expressions that predict or indicate future events or trends or that are not statements of historical matters, although not all forward-looking statements contain such identifying words. In making these statements, we rely upon assumptions and analysis based on our experience and perception of historical trends, current conditions, and expected future developments, as well as other factors we consider appropriate under the circumstances. We believe these judgments are reasonable, but these statements are not guarantees of any future events or financial results. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond our control.
These forward-looking statements are subject to a number of risks and uncertainties, including changes in domestic and foreign business, market, financial, political and legal conditions; failure to realize the anticipated benefits of the business combination; future global, regional or local economic and market conditions; the development, effects and enforcement of laws and regulations; our ability to manage future growth; our ability to develop new products and services, bring them to market in a timely manner and make enhancements to our platform; the effects of competition on our future business; our ability to issue equity or equity-linked securities; the outcome of any potential litigation, government and regulatory proceedings, investigations and inquiries; and those factors described or referenced in filings with the Securities and Exchange Commission. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that we do not presently know or that we currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect our expectations, plans or forecasts of future events and views as of the date of this press release. We anticipate that subsequent events and developments will cause our assessments to change.
We caution readers not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other factors that affect the subject of these statements, except where we are expressly required to do so by law. All written and oral forward-looking statements attributable to us are expressly qualified in their entirety by this cautionary statement.
Contacts: Investors Cody Slach Gateway Group, Inc. 949-574-3860 BTM@gateway-grp.com
Media Brenlyn Motlagh, Ryan Deloney Gateway Group, Inc. 949-574-3860 BTM@gateway-grp.com
Euroseas Ltd. was formed on May 5, 2005 under the laws of the Republic of the Marshall Islands to consolidate the ship owning interests of the Pittas family of Athens, Greece, which has been in the shipping business over the past 140 years. Euroseas trades on the NASDAQ Capital Market under the ticker ESEA. Euroseas operates in the container shipping market. Euroseas’ operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004 certified affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. Euroseas employs its vessels on spot and period charters and through pool arrangements.
Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.
Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Third quarter financial results. Total net revenues for the third quartertotaled $56.9 million, a 5.1% increase year-over-year, but modestly lower than our estimate of $59.2 million. Adjusted EBITDA and EPS were $38.8 million and $4.23, respectively, below our estimates of $41.7 million and $4.40. The lower-than-expected results were due primarily to a greater number of scheduled off-hire days and expenses associated with a special survey and drydock completed on one vessel during the quarter. Total operating expenses amounted to $24.4 million compared to $23.5 million during the prior year period and our $23.1 million estimate. Drydocking expenses were $2.7 million compared to our estimate of $0.6 million.
Revenue and earnings visibility into 2026. With 100% of Q4 2025 operating days secured at an average rate of ~$30,345 per day and 74.7% of 2026 days already covered at higher average rates of ~$31,300 per day, Euroseas has locked in substantial revenue visibility. This robust charter coverage not only underpins earnings but also provides a strong buffer against rate volatility, positioning the company to benefit from sustained high utilization into 2026.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
Adobe’s latest acquisition marks one of the most significant moves yet in the evolution of how brands manage visibility, discoverability, and customer engagement in an AI-driven world. On November 19, 2025, Adobe announced a definitive agreement to acquire Semrush Holdings, Inc. in an all-cash deal valued at approximately $1.9 billion, or $12.00 per share. The acquisition unites Adobe’s expansive customer experience and content orchestration tools with Semrush’s deep capabilities in search engine optimization (SEO) and the rapidly emerging field of generative engine optimization (GEO).
Adobe has been at the forefront of enabling enterprises to reimagine their customer experience workflows through agentic AI—AI that can plan, initiate, and optimize tasks autonomously. Tools such as Adobe Experience Manager (AEM), Adobe Analytics, and the newly introduced Adobe Brand Concierge reflect the company’s commitment to helping brands create, manage, and deliver content at scale. These products support a content supply chain that aligns with the needs of enterprises navigating new customer interfaces powered by large language models (LLMs).
Semrush’s inclusion strengthens Adobe’s position dramatically. As brands increasingly confront the challenge of remaining visible across traditional search engines and emerging AI-driven discovery channels, Semrush provides a powerful layer of intelligence and optimization. The company is widely known for its decade-long leadership in SEO analytics and has recently become a leading force in GEO—an emerging discipline focused on helping brands remain discoverable within AI-powered platforms, from LLMs to generative search engines.
The acquisition comes at a time when consumer behavior is rapidly shifting. With more customers receiving answers, recommendations, and purchase guidance from platforms like ChatGPT and Google Gemini, brand visibility is no longer confined to search engine rankings or owned channels. It now includes how a brand appears within LLM outputs, conversational AI systems, and algorithm-driven summaries. Organizations that fail to adapt to these dynamics risk losing relevance across key digital touchpoints.
Semrush brings enterprise-grade capabilities and impressive momentum to Adobe’s ecosystem. Its generative marketing tools are already being used by major brands, and the company recently reported 33% year-over-year Annual Recurring Revenue growth in its enterprise segment. This traction reflects a growing need among marketers who now rely on SEO and GEO teams to drive visibility strategies in generative environments.
Together, Adobe and Semrush will offer marketers a unified solution that spans the entire spectrum of brand exposure—owned websites, search engines, LLM responses, and the broader web. By integrating Semrush’s data intelligence into Adobe’s customer experience tools, the combined platform is designed to give organizations a holistic, real-time understanding of how their brand appears and performs across both traditional and AI-driven discovery channels.
This acquisition positions Adobe to become a central player in helping enterprises navigate the next phase of AI-enabled marketing. As AI continues reshaping how consumers gather information, evaluate options, and make buying decisions, Adobe’s expanded ecosystem aims to ensure that brands remain both discoverable and competitive in an increasingly complex digital landscape.
Bitcoin’s recent sharp downturn has become one of the most talked-about developments in global markets, not only because of the scale of the decline but because of how dramatically it diverges from the performance of nearly every major asset class. While the world’s largest cryptocurrency has fallen close to 30% from its highs, traditional investments such as gold, long-term Treasuries, and several equity sectors have moved in the opposite direction, highlighting a shift in risk appetite that is challenging assumptions about Bitcoin’s role within a diversified portfolio.
Gold has been one of the clearest contrasts. For years, Bitcoin supporters positioned the asset as “digital gold,” a modern alternative that could offer the same inflation-hedging and store-of-value qualities while delivering far stronger growth potential. Yet 2025 has told a different story. As Bitcoin has weakened, gold has steadily climbed, supported by falling interest rates, macroeconomic caution, and investors reverting to the familiarity of a centuries-old safe haven. Instead of moving in tandem, the two assets have decoupled, with gold benefiting from fear while Bitcoin has absorbed the pressure of risk-off sentiment.
Bonds have also outperformed Bitcoin, despite being viewed as some of the most conservative instruments available. With global central banks shifting toward lower rates and expectations for slower economic growth building, long-term Treasuries have enjoyed a meaningful rally. These gains have been especially striking when compared with Bitcoin, which has struggled to attract inflows in an environment where investors are prioritizing stability over high-volatility assets. The comparison underscores how Bitcoin’s risk profile still aligns more with speculative tech than with defensive or income-generating investments.
Tech stocks offer another dimension to the divergence. Despite pockets of volatility tied to earnings and shifting valuations, many tech names—especially large-cap leaders—have held up better than Bitcoin. Lower rates have helped the sector maintain some resilience, and tech remains a favored destination for investors seeking long-term growth. Bitcoin, however, has not benefited from the same support, partly due to the lingering psychological effects of October’s steep liquidation event, where billions in leveraged crypto positions were wiped out in a matter of hours.
Even sectors traditionally considered slow or predictable have outpaced Bitcoin. Utilities, often ignored during high-growth periods, have returned to favor as investors shift toward assets offering stability and lower correlation with market swings. Their ability to outperform Bitcoin reinforces the degree to which risk sentiment has changed during the year. Emerging market equities have also benefited from global rate moves and a refreshed appetite for select developing economies, adding another category that has outperformed the cryptocurrency.
This multi-asset comparison paints a clear picture: Bitcoin is still functioning as a high-beta asset closely tied to speculative momentum rather than acting as a hedge or a defensive anchor. When markets favor safety, income, or measured growth, gold, bonds, and stable equity sectors take the lead. When markets are optimistic and liquidity is abundant, Bitcoin tends to outperform. In 2025, the tide has shifted toward caution, and Bitcoin’s performance reflects that shift more starkly than ever.
Although the longer-term narrative for Bitcoin remains intact for many investors, the current landscape shows that the cryptocurrency continues to behave as a risk-sensitive asset rather than a universal hedge. As the year progresses, Bitcoin’s next major move will likely depend on whether global markets transition back toward risk-on sentiment or continue rewarding defensive positioning across traditional asset classes.
